XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Assets    
Cash and due from banks $ 282,250 $ 251,541
Interest bearing deposits with banks 184,347 177,088
Investment securities:    
Held to maturity (fair value of $2,066,970 at March 31, 2019 and $2,034,943 at December 31, 2018) 2,074,399 2,068,246
Available for sale 1,723,106 1,749,544
Total investment securities 3,797,505 3,817,790
Loans held for sale, at fair value 31,903 35,155
Loans 25,423,118 25,035,469
Less: Allowance for loan losses (154,381) (151,859)
Net loans 25,268,737 24,883,610
Premises and equipment, net 312,677 341,630
Lease right of use assets 289,669  
Bank owned life insurance 440,845 439,602
Accrued interest receivable 100,722 95,296
Goodwill 1,084,665 1,084,665
Other intangible assets, net 73,580 76,990
Other assets 610,091 659,721
Total Assets 32,476,991 31,863,088
Deposits:    
Non-interest bearing 6,352,135 6,175,495
Interest bearing:    
Savings, NOW and money market 11,447,043 11,213,495
Time 7,108,318 7,063,984
Total deposits 24,907,496 24,452,974
Short-term borrowings 2,062,576 2,118,914
Long-term borrowings 1,499,727 1,654,268
Junior subordinated debentures issued to capital trusts 55,457 55,370
Lease liabilities 313,525 3,125
Accrued expenses and other liabilities 193,331 227,983
Total Liabilities 29,032,112 28,512,634
Shareholders’ Equity    
Common stock (no par value, authorized 450,000,000 shares; issued 332,062,473 shares at March 31, 2019 and 331,634,951 shares at December 31, 2018) 116,466 116,240
Surplus 2,799,434 2,796,499
Retained earnings 375,983 299,642
Accumulated other comprehensive loss (53,257) (69,431)
Treasury stock, at cost (329,837 common shares at March 31, 2019 and 203,734 common shares at December 31, 2018) (3,438) (2,187)
Total Shareholders’ Equity 3,444,879 3,350,454
Total Liabilities and Shareholders’ Equity 32,476,991 31,863,088
Series A    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares 111,590 111,590
Series B    
Shareholders’ Equity    
Preferred stock, no par value; authorized 50,000,000 shares $ 98,101 $ 98,101